-
31 May 2023
-
Sometimes people avoid talking about uncertainty in scientific findings…but they shouldn't! Gain insights and practical advice on how to communicate uncertainty in this free resource.
Science is complicated and inherently uncertain – it’s hard for scientists and researchers to know how to talk with diverse audiences about this. We are...
31 May 2023
-
25 May 2023
-
25 May 2023
-
24 May 2023
-
Introducing "Las claves de la evidencia en salud" by Cochrane Iberoamerica—a dynamic Spanish course that delves into evidence-based healthcare, clinical trials, and Cochrane evidence. Designed for healthcare consumers (patients, care givers, family members), policy makers, and the healthcare team, this interactive course offers five modules, each...
23 May 2023
-
22 May 2023
-
It is with great sadness that we mark the passing of Hyeong Sik Ahn, Director of Cochrane Korea, Professor at the Department of Preventive Medicine, and former Dean of the Graduate School of Public Health at Korea University.
Professor Ahn's enduring relationship with Cochrane, spanning over twenty years, began when he attended his first Cochrane...
19 May 2023
-
Cochrane, a global independent network of researchers, professionals, patients, carers, and health enthusiasts, proudly announces the publication of its latest Special Collection titled "Cochrane at 30: what our 30th year can tell us about the future."
In an era where access to health evidence has expanded, the risk of misinterpreting...
19 May 2023
-
The Cochrane Colloquium is a premier event for those interested in evidence-based healthcare decision-making. It brings together individuals involved in evidence production, dissemination, implementation, and policy-making, as well as those making individual healthcare decisions. The 2023 Cochrane Colloquium will take place in London, UK from 4th...
16 May 2023
-
Interventions aimed at reducing work-related stress for individual healthcare workers may lead to improvements in how people cope with stress up to a year later. Findings from a Cochrane review of the latest available evidence build on the conclusions of a previous review in 2015 that found low-quality evidence that interventions, such as...
12 May 2023
-
11 May 2023
-
11 May 2023
-
Stroke, heart disease, hypertension and peripheral vascular diseases are leading global causes of mortality and morbidity. As the population ages and these conditions become more common in low-income countries, the need for an integrated response has become increasingly clear.
The new Heart, Stroke and Circulation Thematic Group aims to bring...
10 May 2023
-
Characterised by close collaboration and cross-disciplinary expertise, Cochrane’s new People, Health Systems and Public Health Thematic Group is led by Rebecca Ryan (CCC, La Trobe University Australia), Luke Wolfenden (CPH, University of Newcastle, Australia), Simon Lewin (EPOC, Norwegian University of Science and Technology) and Sasha...
10 May 2023
-
Largest ever investigation into antidepressants used for chronic pain shows insufficient evidence to determine how effective or harmful they may be.
Study reviewed commonly prescribed medications including amitriptyline, duloxetine, fluoxetine, citalopram, paroxetine, and sertraline.
One third of people globally are living with long-term pain with...
10 May 2023
-
Cochrane Rehabilitation will represent Cochrane in an upcoming side event at the 76th World Health Assembly (WHA). The event, titled "Strengthening Rehabilitation in Health Systems - Responding to the new WHA Resolution" aims to raise awareness of evidence-based health policies and advocate for the integration of rehabilitation services into...
5 May 2023
-
5 May 2023
-
5 May 2023
-
At Cochrane, we aim to collaborate and create reliable synthesized evidence, making it accessible to all. We are dedicated to promoting access and the widest possible dissemination of our valuable evidence.
We're now making some big improvements to help continue that mission, by changing the way we share the data that is associated with Cochrane...
4 May 2023